Industry groups have identified upfront costs as a barrier to streamlining U.S. drugmaking. The nonprofit API Innovation Center has a proposed answer for how to tilt finances in favor of investments ...

ESTEVE CDMO, a global CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, began a $15.5 ...

AbbVie’s North Chicago expansion adds two state-of-the-art API plants intended to support next-generation neuroscience and obesity portfolios via advanced manufacturing technologies and artificial ...

Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.

From its 17-year development cycle through to its commercial launch, production has always been in Yeztugo’s DNA. | From its ...

Investment marks continued progress against AbbVie's $100 billion commitment to U.S. research and development (R&D) and capital investments, including manufacturing, over the next decade Two new ...

With Renishaw and Apex Additive Technologies, Addiguru is working to combine its multi-sensor monitoring platform, integrating optical, near-infrared (NIR), and long-wave infrared (LWIR) sensing, with ...

South Africa’s National AIDS Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end AIDS in the country by 2043 – ...

New automation consulting and implementation platform helps enterprises streamline operations, deploy AI agents, and scale productivity across departments.

ESTEVE CDMO, the global pure-play CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, today announced that it had commenced a $15.5-million investment to enhance ...